Postmenopausal bleeding (PMB), the pink flag symptom for endometrial most cancers, triggers pressing investigation by transvaginal ultrasound scan, hysteroscopy and/or endometrial biopsy. These investigations are pricey, invasive and sometimes painful or distressing for girls. In a pilot examine, we discovered that voided urine and non-invasive vaginal samples from girls with endometrial most cancers include malignant cells that may be recognized by cytology. The goal of the DEveloping Checks for Endometrial Most cancers deTection (DETECT) Research is to find out the diagnostic check accuracy of urine and vaginal cytology for endometrial most cancers detection in girls with PMB.
This can be a multicentre diagnostic accuracy examine of ladies referred to secondary care with PMB. Eligible girls will likely be requested to offer a self-collected voided urine pattern and a vaginal pattern collected with a Delphi screener earlier than routine medical procedures. Pairs of specialist cytologists, blinded to participant most cancers standing, will assess and classify samples independently, with variations settled by consensus evaluation or involving a 3rd cytologist. Outcomes will likely be in contrast with medical outcomes from normal diagnostic exams.
A pattern measurement of 2000 girls could have 80% energy to determine a sensitivity of vaginal samples for endometrial most cancers detection by cytology of ≥85%±7%, assuming 5% endometrial most cancers prevalence. The first goal is to find out the diagnostic accuracy of urogenital samples for endometrial most cancers detection by cytology. Secondary aims embody the acceptability of urine and vaginal sampling to girls.
Is Analysis of Low-Grade Urothelial Carcinoma Potential in Urine Cytology?
Urine cytology is a helpful modality, primarily for the prognosis and follow-up surveillance of high-grade urothelial carcinoma (HGUC). Its utility in diagnosing low-grade urothelial carcinoma (LGUC) stays controversial due to low reported sensitivity in comparison with cystoscopy. To check the cytomorphology of LGUC in voided urine samples and analyze its utility in prognosis.
This can be a retrospective examine of 1 12 months, together with 48 voided urine samples in instances which had been confirmed as LGUC on subsequent histology. Urine cytology smears of those instances, initially stained with Papanicolaou stain had been reviewed, critically analyzed and the particular cytomorphologic and cystoscopic findings had been documented. Though medical information and former cytological info should assist guiding, authors thought of that CINtec® is a extremely legitimate check for the prognosis of persistent HPV infections within the feminine inhabitants.
On evaluation 18 samples had been re-categorized as LGUC which included 10 samples initially recognized as Adverse for HGUC, 2 as Atypical Urothelial Cells – Not In any other case Specified (AUC-NOS) and 6 as Suspicious for Carcinoma. As well as, one other three samples with preliminary prognosis of LGUC remained as LGUC on evaluation. Thus, a complete of 21 LGUC samples had been recognized after the evaluation. 26 (54%) samples with a prognosis of detrimental for HGUC remained detrimental even after evaluation, because the tumor cells weren’t recognized both resulting from sampling error or unrecognizable morphology.
One (2%) samples of AUC-NOS remained the identical on evaluation resulting from very scant atypical cells. In 21 LGUC samples, cytology confirmed a twin inhabitants of benign differentiated urothelial cells and small urothelial cells with refined nuclear atypia akin to irregular and thickened nuclear membrane with elevated nuclear cytoplasmic ratio. In 12 false detrimental LGUC samples, the diagnostic cells had been camouflaged by their refined nuclear atypia coupled with an awesome background of differentiated benign urothelial cells as each appeared virtually comparable in morphology. Papillary fragments had been recognized solely in 2 samples.
Analysis of Position of Visible Inspection Utilizing Acetic Acid (VIA) and Exfoliative Cytology in Screening and Early Detection of Oral Premalignant Lesions and Oral Most cancers
Oral most cancers accounts for 50-70% of whole most cancers mortality. VIA screening has drastically modified the morbidity and mortality associated to cervical most cancers. In current examine, we assessed the position of 5% Acetic Acid as a significant stain in oral mucosa of persistent tobacco chewers, to know if it might probably assist in early prognosis and improved prognosis of oral malignancies and to evaluate the sensitivity and specificity of VIA and exfoliative cytology for screening of Oral premalignant and malignant lesions in excessive threat inhabitants with restricted well being care infrastructure.
This was an outpatient division based mostly potential examine carried out in a tertiary hospital over a interval of two years. 150 instances with a historical past of persistent tobacco use had been evaluated. Visible inspection (VI) adopted by VIA utilizing 5% Acetic acid was carried out. Oral scrapes had been taken for cytological examination adopted by biopsy for histopathological analysis, wherever potential. Sensitivity, specificity, PPV, NPV and accuracy of VIA and Exfoliative cytology was 71%, 65%, 83%, 48%, 69% and 98%, 65%, 89%, 92%, 88% respectively protecting histology as gold normal.
In 2016, a modified model of the PSC pointers was adopted on the College of Missouri for classification of sputum, bronchial washing, bronchial brushing, and fine-needle aspiration specimens. Specimens assigned to the detrimental class included all specimens containing evaluatable inflammatory or epithelial cells together with benign showing respiratory epithelium. Solely specimens with marked artifactual distortion or obscuring blood or mucus had been positioned within the non-diagnostic class.
 Cyclin D1 Antibody |
|
AF0931 |
Affbiotech |
200ul |
EUR 420 |
Cyclin D1 Antibody |
|
AF6234 |
Affbiotech |
200ul |
EUR 420 |
 Cyclin D1 antibody |
|
70R-13838 |
Fitzgerald |
100 ug |
EUR 366 |
|
Description: Affinity purified Mouse polyclonal Human Cyclin D1 antibody |
Cyclin D1 antibody |
|
70R-33524 |
Fitzgerald |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal Cyclin D1 antibody |
Cyclin D1 Antibody |
|
47994-100ul |
SAB |
100ul |
EUR 399.6 |
Cyclin D1 Antibody |
|
47994-50ul |
SAB |
50ul |
EUR 286.8 |
Cyclin D1 Antibody |
|
48497-100ul |
SAB |
100ul |
EUR 399.6 |
Cyclin D1 Antibody |
|
48497-50ul |
SAB |
50ul |
EUR 286.8 |
Cyclin D1 Antibody |
|
48619-100ul |
SAB |
100ul |
EUR 399.6 |
Cyclin D1 Antibody |
|
48619-50ul |
SAB |
50ul |
EUR 286.8 |
Cyclin D1 Antibody |
|
DF6386 |
Affbiotech |
200ul |
EUR 420 |
Cyclin D1 Antibody |
|
R36266-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
|
Description: Additional name(s) for this target protein: CCND1 |
Cyclin D1 Antibody |
|
R20262-0.1ML |
NSJ Bioreagents |
100ul |
EUR 347.65 |
|
Description: This recombinant Cyclin D1 antibody reacts to human Cyclin D1. It may also react to the bovine, mouse or rat protein, as predicted by immunogen homology. |
Cyclin D1 Antibody |
|
R30348 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: D-type cyclins are regarded as essential links between cell environment and the core cell cycle machinery. Cyclin D1, the product of the human gene CCND1, is also known as BCL1. Cyclin D1 expression is regulated by the retinoblastoma protein. Expression of Cyclin D1, but not of cyclins A and E, was induced by transfection of the RB gene into RB-deficient tumor cells. The CCND1 gene can function as an oncogene. |
Cyclin D1 Antibody |
|
R30349 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: Cyclin D1, also known as CCND1, belongs to the highly conserved cyclin family whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. CCND1 encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the retinoblastoma protein and promotes progression through the G1-S phase of the cell cycle. Amplification or overexpression of the protein plays pivotal roles in the development of a subset of human cancers including parathyroid adenoma, breast cancer, colon cancer, lymphoma, melanoma, and prostate cancer. The gene is overexpressed in breast cancers and is required for oncogene-induced tumorigenesis. Brisken et al. (2003) found that prolactin (PRL; 176760) induced IGF2 (147470) mRNA and IGF2 induced cyclin D1 protein expression in mouse mammary epithelial cultures. They also concluded that IGF2 is a mediator of prolactin-induced alveologenesis and that prolactin, IGF2, and Cyclin D1 are components of a developmental pathway in mammary gland. |
Cyclin D1 Antibody |
|
R32025 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: Cyclin D1, also known as CCND1, is a human gene. The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclin D1 encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the retinoblastoma protein and promotes progression through the G1-S phase of the cell cycle. Amplification or overexpression of cyclin D1 plays pivotal roles in the development of a subset of human cancers including parathyroid adenoma, breast cancer, colon cancer, lymphoma, melanoma, and prostate cancer. The cyclin D1 gene is overexpressed in human breast cancers and is required for oncogene-induced tumorigenesis. Brisken et al. (2003) found that prolactin induced IGF2 mRNA and IGF2 induced cyclin D1 protein expression in mouse mammary epithelial cultures. And they also concluded that IGF2 is a mediator of prolactin-induced alveologenesis and that prolactin, IGF2, and cyclin D1 are components of a developmental pathway in mammary gland. |
) Cyclin D1 antibody (HRP) |
|
abx445238-100ug |
Abbexa |
100 ug |
EUR 678 |
|
|
 anti- Cyclin D1 antibody |
|
FNab02124 |
FN Test |
100µg |
EUR 606.3 |
|
|
|
Description: Antibody raised against Cyclin D1 |
) Cyclin D1 antibody (FITC) |
|
abx445237-100ug |
Abbexa |
100 ug |
EUR 678 |
|
|
) Cyclin D1 Antibody (CCND1) |
|
F52187-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. Cyclin D1 forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. Mutations, amplification and overexpression of the gene encoding this protein, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. |
Cyclin D1 Antibody (CCND1) |
|
F40063-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: CCND1 belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of the gene encoding this protein, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. |
Cyclin D1 Antibody (CCND1) |
|
F47705-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. |
Cyclin D1 Antibody (CCND1) |
|
F48111-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: CCND1 is the regulatory component of the Cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. CyclinD-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. [UniProt] |
Cyclin D1 Antibody (CCND1) |
|
F48111-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: CCND1 is the regulatory component of the Cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. CyclinD-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. [UniProt] |
Cyclin D1 Antibody (CCND1) |
|
F49118-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: CCND1 belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. |
 Cyclin D1 Antibody / CCND1 |
|
V9073-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Cyclin D1 (CCND1), one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (CCND1+) from CLL/SLL and follicular lymphomas (CCND1-). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express CCND1. |
Cyclin D1 Antibody / CCND1 |
|
V9073-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Cyclin D1 (CCND1), one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (CCND1+) from CLL/SLL and follicular lymphomas (CCND1-). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express CCND1. |
Cyclin D1 Antibody / CCND1 |
|
V9073IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Cyclin D1 (CCND1), one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (CCND1+) from CLL/SLL and follicular lymphomas (CCND1-). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express CCND1. |
Cyclin D1 Antibody / CCND1 |
|
V9073SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Cyclin D1 (CCND1), one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (CCND1+) from CLL/SLL and follicular lymphomas (CCND1-). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express CCND1. |
Cyclin D1 Antibody / CCND1 |
|
V7043-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7043-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7043IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7043PE-100T |
NSJ Bioreagents |
100 Tests |
EUR 349.3 |
|
Description: This antibody recognizes a protein of 36kDa, identified as Cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression. The antibody is useful in identifying mantle cell lymphomas (Cyclin D1 positive) from CLL/SLL and follicular lymphomas (Cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7043SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7337-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as Cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (Cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7337-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 36kDa, identified as Cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (Cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7337IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as Cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (Cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V7337SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as Cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of Cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (Cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2830PE-100T |
NSJ Bioreagents |
100 Tests |
EUR 349.3 |
|
Description: Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2831-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2831-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2831IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2831SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2006-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: This antibody recognizes a protein of 36kDa, identified as Cyclin D1. It is a putative proto-oncogene overexpressed in a wide variety of human neoplasms and a key cell cycle regulator. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression. Cyclin D1 antibody is useful in identifying mantle cell lymphomas, which stain positive, from CLL/SLL and follicular lymphomas, which stain negative. Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2006-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: This antibody recognizes a protein of 36kDa, identified as Cyclin D1. It is a putative proto-oncogene overexpressed in a wide variety of human neoplasms and a key cell cycle regulator. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression. Cyclin D1 antibody is useful in identifying mantle cell lymphomas, which stain positive, from CLL/SLL and follicular lymphomas, which stain negative. Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2006IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: This antibody recognizes a protein of 36kDa, identified as Cyclin D1. It is a putative proto-oncogene overexpressed in a wide variety of human neoplasms and a key cell cycle regulator. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression. Cyclin D1 antibody is useful in identifying mantle cell lymphomas, which stain positive, from CLL/SLL and follicular lymphomas, which stain negative. Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2006PE-100T |
NSJ Bioreagents |
100 Tests |
EUR 349.3 |
|
Description: This antibody recognizes a protein of 36kDa, identified as Cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression. The antibody is useful in identifying mantle cell lymphomas (Cyclin D1 positive) from CLL/SLL and follicular lymphomas (Cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2006SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: This antibody recognizes a protein of 36kDa, identified as Cyclin D1. It is a putative proto-oncogene overexpressed in a wide variety of human neoplasms and a key cell cycle regulator. This antibody neutralizes the activity of Cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression. Cyclin D1 antibody is useful in identifying mantle cell lymphomas, which stain positive, from CLL/SLL and follicular lymphomas, which stain negative. Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V2365PE-100T |
NSJ Bioreagents |
100 Tests |
EUR 349.3 |
|
Description: This antibody recognizes a protein of 36kDa, identified as Cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression. The antibody is useful in identifying mantle cell lymphomas (Cyclin D1 positive) from CLL/SLL and follicular lymphomas (Cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8053-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8053-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8053SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8651-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8651-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8651SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8652-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8652-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
Cyclin D1 Antibody / CCND1 |
|
V8652SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. |
) Cyclin D1 antibody (Biotin) |
|
abx445236-100ug |
Abbexa |
100 ug |
EUR 693.6 |
|
|
) Cyclin D1 antibody (Thr286) |
|
70R-30874 |
Fitzgerald |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal Cyclin D1 antibody (Thr286) |
 Antibody) Cyclin D1 (pS90) Antibody |
|
abx149011-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
Cyclin D1 (pS90) Antibody |
|
abx010300-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
 Antibody) Cyclin D1 (CCND1) Antibody |
|
abx139064-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx232124-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx242422 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
abx224460-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx224352-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx109797 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx100478 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 910.80
-
EUR 477.60
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx100479 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1362.00
-
EUR 661.20
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx100480 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx100481 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx100482 |
Abbexa |
-
EUR 393.60
-
EUR 1011.60
-
EUR 526.80
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx100483 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1545.60
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx176052 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx171973 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx214178 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx214742 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
abx140376-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
|
 Antibody) Cyclin D1 (pT288) Antibody |
|
abx149012-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx133903 |
Abbexa |
-
EUR 427.20
-
EUR 644.40
-
EUR 260.40
|
|
|
|
 Antibody) Cyclin D1 (pT286) Antibody |
|
20-abx121863 |
Abbexa |
-
EUR 376.80
-
EUR 560.40
-
EUR 243.60
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx121864 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
abx117083-100ug |
Abbexa |
100 ug |
EUR 560.4 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx448573-100ug |
Abbexa |
100 ug |
EUR 627.6 |
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx330261 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx327057 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
abx031337-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx031337-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx025054-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx025054-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx034749-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx034749-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx019062-100ug |
Abbexa |
100 ug |
EUR 410.4 |
|
|
Cyclin D1 (CCND1) Antibody |
|
abx038356-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx125309 |
Abbexa |
-
EUR 594.00
-
EUR 844.80
-
EUR 427.20
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx125624 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx123072 |
Abbexa |
|
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx123414 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx328717 |
Abbexa |
|
|
|
|
 Antibody) cyclin D1 (CCND1) Antibody |
|
abx432565-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
|
Cyclin D1 (CCND1) Antibody |
|
20-abx001183 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Cyclin D1 (CCND1) Antibody |
|
abx011703-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
|
Cyclin D1 (pT286) Antibody |
|
20-abx011704 |
Abbexa |
|
|
|
|
 Cyclin D1 Conjugated Antibody |
|
C48619 |
SAB |
100ul |
EUR 476.4 |
Cyclin D1 Conjugated Antibody |
|
C47994 |
SAB |
100ul |
EUR 476.4 |
 Cyclin D1 Polyclonal Antibody |
|
40803-100ul |
SAB |
100ul |
EUR 302.4 |
Cyclin D1 Polyclonal Antibody |
|
40803-50ul |
SAB |
50ul |
EUR 224.4 |
Cyclin D1 Polyclonal Antibody |
|
A71377 |
EpiGentek |
|
|
Cyclin D1 Polyclonal Antibody |
|
A71378 |
EpiGentek |
|
|
Cyclin D1 Polyclonal Antibody |
|
A71380-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Cyclin D1 Polyclonal Antibody |
|
ABP51082-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Human, Mouse, Rat. This Cyclin D1 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cyclin D1 around the non-phosphorylation site of T286 |
Cyclin D1 Polyclonal Antibody |
|
ABP51082-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Human, Mouse, Rat. This Cyclin D1 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cyclin D1 around the non-phosphorylation site of T286 |
Cyclin D1 Polyclonal Antibody |
|
ABP51082-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Human, Mouse, Rat. This Cyclin D1 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cyclin D1 around the non-phosphorylation site of T286 |
Cyclin D1 Polyclonal Antibody |
|
ABP56018-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Human, Mouse, Rat. This Cyclin D1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cyclin D1 around the non-phosphorylation site of S90 |
Cyclin D1 Polyclonal Antibody |
|
ABP56018-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Human, Mouse, Rat. This Cyclin D1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cyclin D1 around the non-phosphorylation site of S90 |
Cyclin D1 Polyclonal Antibody |
|
ABP56018-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Human, Mouse, Rat. This Cyclin D1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Cyclin D1 around the non-phosphorylation site of S90 |
Cyclin D1 Polyclonal Antibody |
|
ABP57275-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Mouse, Rat. This Cyclin D1 antibody is for WB, IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein |
Cyclin D1 Polyclonal Antibody |
|
ABP57275-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Mouse, Rat. This Cyclin D1 antibody is for WB, IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein |
Cyclin D1 Polyclonal Antibody |
|
ABP57275-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Cyclin D1 from Mouse, Rat. This Cyclin D1 antibody is for WB, IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein |
Cyclin D1 Polyclonal Antibody |
|
ES2081-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Cyclin D1 Polyclonal Antibody |
|
ES2081-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Cyclin D1 Polyclonal Antibody |
|
ES8274-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC |
Cyclin D1 Polyclonal Antibody |
|
ES8274-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC |
Cyclin D1 Polyclonal Antibody |
|
ES7017-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cyclin D1 Polyclonal Antibody |
|
ES7017-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cyclin D1 Polyclonal Antibody |
|
EA245-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC |
Cyclin D1 Polyclonal Antibody |
|
EA245-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cyclin D1 from Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC |
) Polyclonal Cyclin D1 Antibody (S90) |
|
APR05053G |
Leading Biology |
0.1ml |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Cyclin D1 (S90). This antibody is tested and proven to work in the following applications: |
 Antibody) Cyclin D1(DCS-6) Antibody |
|
BNCA0007-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cyclin D1(DCS-6), APC conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC810007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF680R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC810007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF680R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC800007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF680 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC800007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF680 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC940007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF594 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC940007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF594 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC880007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF488A conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC880007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF488A conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC430007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF543 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC430007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF543 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC400007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF640R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC400007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF640R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC050007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF405M conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC050007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF405M conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCB0007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Biotin conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCB0007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Biotin conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCAP0007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCAP0007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCR0007-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cyclin D1(DCS-6), RPE conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNUB0007-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Concentration: 0.2mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNUB0007-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Concentration: 0.2mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCP0007-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cyclin D1(DCS-6), PerCP conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCH0007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNCH0007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNUM0007-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against Cyclin D1(DCS-6), 1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC040007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF405S conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC040007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF405S conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC550007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF555 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC550007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF555 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC610007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF660R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC610007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF660R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC680007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF568 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC680007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF568 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC470007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF647 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC470007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF647 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC700007-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF770 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(DCS-6) Antibody |
|
BNC700007-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(DCS-6), CF770 conjugate, Concentration: 0.1mg/mL |
 Antibody) Cyclin D1(CCND1/809) Antibody |
|
BNC800809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF680 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC800809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF680 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC810809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF680R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC810809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF680R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC940809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF594 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC940809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF594 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC700809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF770 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC700809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF770 conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC880809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF488A conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC880809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF488A conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC050809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF405M conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC050809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF405M conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC040809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF405S conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC040809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF405S conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC400809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF640R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC400809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF640R conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCAP0809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCAP0809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCA0809-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), APC conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCB0809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Biotin conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCB0809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Biotin conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCR0809-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), RPE conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCP0809-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), PerCP conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNUM0809-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), 1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCH0809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNCH0809-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNUB0809-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Concentration: 0.2mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNUB0809-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), Concentration: 0.2mg/mL |
Cyclin D1(CCND1/809) Antibody |
|
BNC610809-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cyclin D1(CCND1/809), CF660R conjugate, Concentration: 0.1mg/mL |
In 2016, the Papanicolaou Society of Cytopathology (PSC) proposed a classification scheme for reporting cytologic specimens obtained from the respiratory system. Diagnostic sensitivity, specificity, and threat of malignancy had been reported for endobronchial ultrasound guided high quality needle aspiration however information for different sampling strategies has been poorly documented.
